The healthcare informatics company, Advera Health Analytics, sifted through FDA postmarketing safety reports, and compiled data on side effects for companies producing statin drugs. Advera’s report found that Merck’s Zocor, Mevacor and Vytorin were associated with more muscle-related side effects than other drugs in the class such as Pfizer’s Caduet, AbbVie’s Simcor and AstraZeneca’s blockbuster Crestor. Via Fierce Pharma. Posted September 14, 2015
–Alanna McCatty
